ID

29896

Description

Effect of Valsartan Compared to Enalapril on Sitting Systolic Blood Pressure in Children With High Blood Pressure; ODM derived from: https://clinicaltrials.gov/show/NCT00433836

Link

https://clinicaltrials.gov/show/NCT00433836

Keywords

Versions (3)
  1. 4/25/18 4/25/18 -
  2. 4/25/18 4/25/18 -
  3. 9/20/21 9/20/21 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

April 25, 2018

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Hypertension NCT00433836

English

Eligibility Hypertension NCT00433836

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
male or female, ages 6-17, with a documented history of hypertension
Description

Age | Hypertensive disease

Data type

boolean

Alias
UMLS CUI [1]
C0001779
UMLS CUI [2]
C0020538
must be able to swallow a pill
Description

Able to swallow Pills

Data type

boolean

Alias
UMLS CUI [1,1]
C2712086
UMLS CUI [1,2]
C0994475
must be ≥ 18 kg or ≤160 kg
Description

Body Weight

Data type

boolean

Alias
UMLS CUI [1]
C0005910
mssbp (mean of 3 measurements) must be ≥ 95th percentile, for age, gender and height, at visit 2 (randomization), by office blood pressure measurement
Description

Sitting systolic blood pressure mean Measurement Quantity | Age | Gender | Body Height

Data type

boolean

Alias
UMLS CUI [1,1]
C1319893
UMLS CUI [1,2]
C0444504
UMLS CUI [1,3]
C0242485
UMLS CUI [1,4]
C1265611
UMLS CUI [2]
C0001779
UMLS CUI [3]
C0079399
UMLS CUI [4]
C0005890
patients who are eligible and able to participate in the study and whose parent(s)/guardian(s) consent in writing (written informed consent) to their doing so after the purpose and nature of the investigation has been clearly explained to them. (an assent will be required for some patients depending upon their age and local requirements regarding assents)
Description

Study Subject Participation Status eligible | Informed Consent Parent | Informed Consent Guardian | Informed Consent Age dependent

Data type

boolean

Alias
UMLS CUI [1,1]
C2348568
UMLS CUI [1,2]
C1548635
UMLS CUI [2,1]
C0021430
UMLS CUI [2,2]
C0030551
UMLS CUI [3,1]
C0021430
UMLS CUI [3,2]
C1274041
UMLS CUI [4,1]
C0021430
UMLS CUI [4,2]
C0001779
UMLS CUI [4,3]
C1701901
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
renal artery stenosis
Description

Renal Artery Stenosis

Data type

boolean

Alias
UMLS CUI [1]
C0035067
current diagnosis of heart failure (nyha class ii-iv).
Description

Heart failure New York Heart Association Classification

Data type

boolean

Alias
UMLS CUI [1,1]
C0018801
UMLS CUI [1,2]
C1275491
mssbp ≥ 25% above the 95th percentile
Description

Sitting systolic blood pressure mean

Data type

boolean

Alias
UMLS CUI [1,1]
C1319893
UMLS CUI [1,2]
C0444504
second or third degree heart block without a pacemaker.
Description

Second degree atrioventricular block | Complete atrioventricular block | Artificial cardiac pacemaker Absent

Data type

boolean

Alias
UMLS CUI [1]
C0264906
UMLS CUI [2]
C0151517
UMLS CUI [3,1]
C0030163
UMLS CUI [3,2]
C0332197
concurrent potentially life threatening arrhythmia or symptomatic arrhythmia.
Description

Cardiac Arrhythmia Life Threatening | ARRHYTHMIA SYMPTOMATIC

Data type

boolean

Alias
UMLS CUI [1,1]
C0003811
UMLS CUI [1,2]
C2826244
UMLS CUI [2]
C0741212
clinically significant valvular heart disease.
Description

Heart valve disease

Data type

boolean

Alias
UMLS CUI [1]
C0018824
patient that demonstrates clinically significant ecg abnormalities other than those associated with left ventricular hypertrophy.
Description

ECG abnormality | Exception Left Ventricular Hypertrophy

Data type

boolean

Alias
UMLS CUI [1]
C1832603
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0149721
previous solid organ transplantation except renal, liver or heart transplantation. renal, liver or heart transplant must have occurred at least 6 months prior to enrollment. patient must be on stable doses of immunosuppressive therapy for 3 months and deemed clinically stable by the investigator.
Description

Solid organ Transplantation | Exception Kidney Transplantation | Exception Transplantation of liver | Exception Heart Transplantation | Therapeutic immunosuppression Dosage Stable | Patient Stable status Clinical

Data type

boolean

Alias
UMLS CUI [1,1]
C0440790
UMLS CUI [1,2]
C0040732
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0022671
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0023911
UMLS CUI [4,1]
C1705847
UMLS CUI [4,2]
C0018823
UMLS CUI [5,1]
C0021079
UMLS CUI [5,2]
C0178602
UMLS CUI [5,3]
C0205360
UMLS CUI [6,1]
C0030705
UMLS CUI [6,2]
C0205360
UMLS CUI [6,3]
C0205210
other protocol-defined inclusion/exclusion criteria may apply
Description

Eligibility Criteria Study Protocol

Data type

boolean

Alias
UMLS CUI [1,1]
C1516637
UMLS CUI [1,2]
C2348563
Back to the top of the page

Similar models

Eligibility Hypertension NCT00433836

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Age | Hypertensive disease
Item
male or female, ages 6-17, with a documented history of hypertension
boolean
C0001779 (UMLS CUI [1])
C0020538 (UMLS CUI [2])
Able to swallow Pills
Item
must be able to swallow a pill
boolean
C2712086 (UMLS CUI [1,1])
C0994475 (UMLS CUI [1,2])
Body Weight
Item
must be ≥ 18 kg or ≤160 kg
boolean
C0005910 (UMLS CUI [1])
Sitting systolic blood pressure mean Measurement Quantity | Age | Gender | Body Height
Item
mssbp (mean of 3 measurements) must be ≥ 95th percentile, for age, gender and height, at visit 2 (randomization), by office blood pressure measurement
boolean
C1319893 (UMLS CUI [1,1])
C0444504 (UMLS CUI [1,2])
C0242485 (UMLS CUI [1,3])
C1265611 (UMLS CUI [1,4])
C0001779 (UMLS CUI [2])
C0079399 (UMLS CUI [3])
C0005890 (UMLS CUI [4])
Study Subject Participation Status eligible | Informed Consent Parent | Informed Consent Guardian | Informed Consent Age dependent
Item
patients who are eligible and able to participate in the study and whose parent(s)/guardian(s) consent in writing (written informed consent) to their doing so after the purpose and nature of the investigation has been clearly explained to them. (an assent will be required for some patients depending upon their age and local requirements regarding assents)
boolean
C2348568 (UMLS CUI [1,1])
C1548635 (UMLS CUI [1,2])
C0021430 (UMLS CUI [2,1])
C0030551 (UMLS CUI [2,2])
C0021430 (UMLS CUI [3,1])
C1274041 (UMLS CUI [3,2])
C0021430 (UMLS CUI [4,1])
C0001779 (UMLS CUI [4,2])
C1701901 (UMLS CUI [4,3])
Item Group
C0680251 (UMLS CUI)
Renal Artery Stenosis
Item
renal artery stenosis
boolean
C0035067 (UMLS CUI [1])
Heart failure New York Heart Association Classification
Item
current diagnosis of heart failure (nyha class ii-iv).
boolean
C0018801 (UMLS CUI [1,1])
C1275491 (UMLS CUI [1,2])
Sitting systolic blood pressure mean
Item
mssbp ≥ 25% above the 95th percentile
boolean
C1319893 (UMLS CUI [1,1])
C0444504 (UMLS CUI [1,2])
Second degree atrioventricular block | Complete atrioventricular block | Artificial cardiac pacemaker Absent
Item
second or third degree heart block without a pacemaker.
boolean
C0264906 (UMLS CUI [1])
C0151517 (UMLS CUI [2])
C0030163 (UMLS CUI [3,1])
C0332197 (UMLS CUI [3,2])
Cardiac Arrhythmia Life Threatening | ARRHYTHMIA SYMPTOMATIC
Item
concurrent potentially life threatening arrhythmia or symptomatic arrhythmia.
boolean
C0003811 (UMLS CUI [1,1])
C2826244 (UMLS CUI [1,2])
C0741212 (UMLS CUI [2])
Heart valve disease
Item
clinically significant valvular heart disease.
boolean
C0018824 (UMLS CUI [1])
ECG abnormality | Exception Left Ventricular Hypertrophy
Item
patient that demonstrates clinically significant ecg abnormalities other than those associated with left ventricular hypertrophy.
boolean
C1832603 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0149721 (UMLS CUI [2,2])
Solid organ Transplantation | Exception Kidney Transplantation | Exception Transplantation of liver | Exception Heart Transplantation | Therapeutic immunosuppression Dosage Stable | Patient Stable status Clinical
Item
previous solid organ transplantation except renal, liver or heart transplantation. renal, liver or heart transplant must have occurred at least 6 months prior to enrollment. patient must be on stable doses of immunosuppressive therapy for 3 months and deemed clinically stable by the investigator.
boolean
C0440790 (UMLS CUI [1,1])
C0040732 (UMLS CUI [1,2])
C1705847 (UMLS CUI [2,1])
C0022671 (UMLS CUI [2,2])
C1705847 (UMLS CUI [3,1])
C0023911 (UMLS CUI [3,2])
C1705847 (UMLS CUI [4,1])
C0018823 (UMLS CUI [4,2])
C0021079 (UMLS CUI [5,1])
C0178602 (UMLS CUI [5,2])
C0205360 (UMLS CUI [5,3])
C0030705 (UMLS CUI [6,1])
C0205360 (UMLS CUI [6,2])
C0205210 (UMLS CUI [6,3])
Eligibility Criteria Study Protocol
Item
other protocol-defined inclusion/exclusion criteria may apply
boolean
C1516637 (UMLS CUI [1,1])
C2348563 (UMLS CUI [1,2])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial